SWT1

Across TCGA pan-cancer cohorts, SWT1 Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated SWT1 data layer compared with 23 for mass-spec protein.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher SWT1 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated SWT1 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

ACC, UCEC, and KIRC are the cancer types where SWT1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Median	All	0.010	0.667	<.001	45	view →
UCEC	DFS	Median	II,III,IV	0.896	0.425	.011	20	view →
KIRC	OS	Median	All	0.172	0.657	.003	12	view →
LIHC	OS	Median	All	0.105	0.774	.002	3	view →
SKCM	DFS	Median	II,III,IV	0.192	0.707	.046	3	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

SWT1–ACC (DFS)

Open the ACC breakdown →